On Wednesday—for only the second time—the Food and Drug Administration approved a cutting-edge therapy that genetically modifies a patient’s blood cells in order to attack cancer. This time the therapy, known as CAR T-cell therapy, is designed to treat aggressive non-Hodgkin lymphoma.
Source: The FDA Just Approved Another Promising Immunotherapy For Cancer
Could the Food and Drug Administration classify the Apple Watch as a medical device? It’s a question many have asked over the past couple of years, but the stakes are now higher for the Watch…
Source: Don’t wait for the Apple Watch to dole out medical advice anytime soon | TechCrunch
This week, it showed off the latest results of that effort, turning up more than a dozen new mutations associated with the disease.
Source: 23andMe Is Digging Through Your Data for a Parkinson’s Cure | WIRED
Three years after IBM began selling Watson for Oncology to recommend cancer treatments, it’s falling short of the lofty expectations IBM created for it.
Source: IBM pitched Watson as a revolution in cancer care. It’s nowhere close
Doc.ai develops a platform for patients to have personalized artificial intelligence-powered conversations about their health.
Source: Blockchain-based robo-doctors on the horizon | ITWeb